Phase II study of R-mini CHP for elderly patients with diffuse large B cell lymphoma
- Conditions
- diffuse large B cell lymphoma
- Registration Number
- JPRN-UMIN000011234
- Lead Sponsor
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Not provided
1.presence of active infeciton 2.presence of central nervous invasion 3.past history of glaucoma. 4.past history of severe drug allergy. 5.HIV Ab positive or HTLV-1 Ab positive. 6.HBsAg positive or HCV Ab positive. 7.severe cardiac disease 8.hepatic cirrhosis 9.uncontrollable diabetis melitus 10.patients with dialysis 11.lung fibrosis or interstitial pneumonitis 12.other active malignancies 13.pregnant or feeding female 14.severe mental disorder 15.continuous systemic administration of steroid 16.judged for inappropriate with other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2-year progression free survival
- Secondary Outcome Measures
Name Time Method 2-year over all survival, (complete) remission rate, safety, incidence of febrile neutropenia